top of page
Having worked on both the rheumatoid arthritis (RA) and psoriatic arthritis (PsA) indications of Xeljanz, I was a natural choice to help lead the launch and creative for the ulcerative colitis (UC) indication (as well as the unbranded ulcerative colitis work, TalkingUC). In addition, I worked on the extended release (XL) formulation, the indication agnostic Xeljanz master-brand creative, and the award-winning CRM program. Below is just a small sampling of the multitude of work I’ve been a part of across the Xeljanz brand over the years.
RA
PsA
UC
bottom of page